|
Re: About that stroke failure
|
1
|
Resverlogix Corp.
|
Dec 13, 2019 07:54PM
|
|
BiOasis website is outdated and in need of updating
|
1
|
BIOASIS TECHNOLOGIES INC
|
Feb 26, 2016 07:54AM
|
|
Re: Finally got around to this. UN-official, of course
|
1
|
Resverlogix Corp.
|
Sep 17, 2015 02:46PM
|
|
Re: Mace Events Study / Type 2 Diabetes / Control Arms 26 CVOT Trials
|
1
|
Resverlogix Corp.
|
Nov 29, 2018 10:38AM
|
|
Re: Any thoughts on ESPR's climb?
|
1
|
Resverlogix Corp.
|
Feb 08, 2017 08:53AM
|
|
Re: Resverlogix Announces Overnight Marketed Equity Offering
|
1
|
Resverlogix Corp.
|
Jun 08, 2017 04:53PM
|
|
Re: Celgene inks $1B deal for a preclinical epigenetic blood cancer drug from Canada.
|
1
|
Zenith Epigenetics
|
Feb 10, 2019 10:07PM
|
|
Re: Still waiting for a sufficient answer
|
1
|
Resverlogix Corp.
|
May 22, 2018 03:58PM
|
|
June Corporate Presentation
|
1
|
BIOASIS TECHNOLOGIES INC
|
Jun 30, 2020 10:36AM
|
|
Re: Resverlogix Announces Lead Drug Apabetalone Publication and Presentation at BIO International 2017
|
1
|
Resverlogix Corp.
|
Jun 06, 2017 11:20AM
|
|
Re: BETonMACE Enrollment
|
1
|
Resverlogix Corp.
|
Feb 22, 2019 04:10PM
|
|
Re: RVX FILES ANNUAL INFO FORM
|
1
|
Resverlogix Corp.
|
Jul 28, 2015 01:43PM
|
|
Bioasis Announces Filing of Its Quarterly Financial Statements and MD&A for the Period Ending August 31, 2019
|
1
|
BIOASIS TECHNOLOGIES INC
|
Oct 25, 2019 10:39PM
|
|
Re: AHA late breaking abstract
|
1
|
Resverlogix Corp.
|
Nov 10, 2019 01:22PM
|
|
Re: Herceptin
|
1
|
BIOASIS TECHNOLOGIES INC
|
Apr 29, 2018 07:53AM
|
|
Re: No mention of efficacy again...
|
1
|
Resverlogix Corp.
|
Mar 28, 2019 05:41PM
|
|
Re: 57th ERA-EDTA Congress Abstracts
|
1
|
Resverlogix Corp.
|
Jun 08, 2020 05:41PM
|
|
2017 Review Paper on RVX-208
|
1
|
Resverlogix Corp.
|
May 10, 2017 03:14PM
|
|
Re: Merge both Zenith and Resverlogic....
|
1
|
Resverlogix Corp.
|
Sep 15, 2015 10:43AM
|
|
Re: NR on Madrid conferece
|
1
|
Resverlogix Corp.
|
May 31, 2017 09:44AM
|
